Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 25,530 | 25,032 | 20,710 | 20,933 | 19,005 |
| Operating Income | -25,530 | -25,032 | -20,710 | -20,933 | -19,005 |
| Other Income | 2,483 | 4,546 | 1,671 | -16 | 2,205 |
| Pre-tax Income | -23,047 | -20,487 | -19,039 | -20,949 | -16,800 |
| Income Tax | 95 | 72 | 65 | 39 | N/A |
| Net Income Continuous | -23,142 | -20,559 | -19,103 | -20,988 | -16,800 |
| Net Income | $-23,142 | $-20,559 | $-19,103 | $-20,988 | $-16,800 |
| EPS Basic Total Ops | -0.30 | -0.30 | -0.33 | -0.39 | -0.42 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -0.33 | -0.39 | -0.42 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.33 | -0.39 | -0.42 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -0.33 | -0.39 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.30 | -0.33 | -0.39 | -0.53 |
| EBITDA(a) | $-25,220 | $-24,734 | $-20,408 | $-20,572 | $-18,672 |